FDA Import Refusal SCS-0763347-7/54/1 — Guangdong Hongli Pharmaceutical Co., Ltd
The FDA refused shipment SCS-0763347-7/54/1 from Guangdong Hongli Pharmaceutical Co., Ltd (China) on Jul 14, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Jul 14, 2025
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75